Halle S, Dasch G A
J Clin Microbiol. 1980 Sep;12(3):343-50. doi: 10.1128/jcm.12.3.343-350.1980.
A microplate enzyme-linked immunosorbent assay (ELISA), developed for the detection of antibodies to typhus group rickettsiae, was used to analyze human sera from individuals engaged directly or indirectly in rickettsial research. The earliest serum available from each of 112 individuals was tested for immunoglobulin M (IgM) and IgG antibodies against Rickettsia typhi and Rickettsia prowazekii by ELISA at a 1:500 dilution. In at least one assay, nine sera had ELISA optical densities of greater than 0.2, which were above the mean optical densities plus three standard deviations of the other 103 sera. Three of the positive sera were from individuals with known clinical cases of typhus infection. The other sera with predominantly IgG titers were from individuals with extended laboratory exposure to rickettsiae or histories of typhus vaccination, or both. During continued serological surveillance, eight additional people with repeated occupational exposure to typhus rickettsiae had seroconversions in the ELISA to optical densities of greater than 0.2. No apparent clinical illness occurred in two individuals, whereas six clinical cases of infection occurred in others subsequent to accidental laboratory autoinoculation (one) or aerosol exposures (five). In the clinical infections, antibodies were first detected at 7 days, but in subsequent sera, rises and declines in titers were quite variable and were influenced by vaccination, relapse, and time and extent of antibiotic therapy. In primary infections the sera of several individuals who received immediate antibiotic therapy had brief strong IgM responses without pronounced increases in IgG. In contrast, much higher IgG levels were attained in three cases in which relapse occurred, the individual had previously been immunized, or treatment had been delayed. The microplate ELISA proved to be a highly sensitive and reliable test for detection of the human serological response to typhus antigens.
一种用于检测斑疹伤寒群立克次体抗体的微孔板酶联免疫吸附测定(ELISA),被用于分析直接或间接参与立克次体研究的人员的血清。通过ELISA对112名个体中每人最早可获得的血清进行检测,以1:500的稀释度检测针对伤寒立克次体和普氏立克次体的免疫球蛋白M(IgM)和IgG抗体。在至少一次检测中,9份血清的ELISA光密度大于0.2,高于其他103份血清的平均光密度加三个标准差。其中3份阳性血清来自已知患斑疹伤寒感染临床病例的个体。其他主要为IgG滴度的血清来自长时间在实验室接触立克次体的个体或有斑疹伤寒疫苗接种史的个体,或两者兼具。在持续的血清学监测中,另外8名反复职业性接触斑疹伤寒立克次体的人员在ELISA检测中出现血清转化,光密度大于0.2。2名个体未出现明显临床疾病,而其他6名个体在意外实验室自身接种(1例)或气溶胶暴露(5例)后发生感染临床病例。在临床感染中,抗体最早在7天被检测到,但在随后的血清中,滴度的上升和下降变化很大,并受疫苗接种、复发以及抗生素治疗的时间和程度影响。在初次感染中,几名接受即时抗生素治疗的个体血清有短暂强烈的IgM反应,而IgG没有明显升高。相比之下,在3例复发、个体先前已免疫或治疗延迟的病例中,IgG水平要高得多。微孔板ELISA被证明是检测人类对斑疹伤寒抗原血清学反应的高度敏感和可靠的检测方法。